UniProtKB/Swiss-Prot Q99972: Variant p.Gln337Glu

Myocilin
Gene: MYOC
Feedback?

Variant information Variant position:

337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamine (Q) to Glutamate (E) at position 337 (Q337E, p.Gln337Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (Q) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In GLC1A; uncertain significance. Any additional useful information about the variant.

Sequence information Variant position:

337 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

504 The length of the canonical sequence.
Location on the sequence:

ILPRPLESTGAVVYSGSLYF Q GAESRTVIRYELNTETVKAE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ILPRPLESTGA------VVYSGSLYFQGAESR---------------------------------------TVIRYELNTETVKAE

                              VLPRPLESTGA------VVYRGSLYFQGAGSG---------

Mouse                         VLPRALESTGA------VVYAGSLYFQGAESR---------

Rat                           VLPQALESTGA------VVYSGSLYFQGAESR---------

Bovine                        VLPRPLESTGA------VVYRGSLYFQAAESR---------

Rabbit                        VLPRSLESTGA------VVYAGSLYFQGAGSR---------

Cat                           VLPRPLESTGA------VVYWGSLYFQGAESR---------

Slime mold                    VMVHPILSANKLSPRFLIVTKQAIYLIKLKQKKNLATYLLD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	33 – 504	Myocilin
Chain	227 – 504	Myocilin, C-terminal fragment
Domain	244 – 503	Olfactomedin-like
Disulfide bond	245 – 433
Beta strand	333 – 338

Literature citations
Mutations in the third exon of the MYOC gene in Spanish patients with primary open angle glaucoma.
Vazquez C.M.; Herrero O.M.V.; Bastus B.M.; Perez V.D.;
Ophthalmic Genet. 21:109-115(2000)
Cited for: VARIANTS GLC1A LYS-261 AND GLU-337; VARIANT ARG-398;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.